Fact based stock research
Convatec Group (LSE:CTEC)
GB00BD3VFW73
How to read the free ranks
For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. The higher the rank, the better the stock performs than its peers. And, we do this for six investment strategies:
Value - shows how good of a value the stock is. Green is "inexpensive"; red is "expensive".
Growth - shows a company's growth potential. Green is "high growth" expected; red is "tough times ahead".
Safety - relates to the amount of debt a company has. Green is low debt level; red is high debt level.
Combined Financial - this isn't an average of the first three ranks but rather a consolidated view across several financial indicators. Green = good; red = tread carefully.
(NEW) Sentiment - quantifies professional analyst ratings and holdings as well as market pulse. Green = positive sentiment; red = skepticism (Only available to Premium Subscribers).
(NEW) 360° View - the ultimate rating with all financial and non-financial indicators.
Convatec Group stock research in summary
ANALYSIS: With an Obermatt Combined Rank of 1 (worse than 99% compared with investment alternatives), Convatec Group (Health Care Supplies, United Kingdom) shares have lower financial characteristics compared with similar stocks. Shares of Convatec Group are low in value (priced high) with a consolidated Value Rank of 47 (worse than 53% of alternatives), show below-average growth (Growth Rank of 23), and are riskily financed (Safety Rank of 12), which means above-average debt burdens. ...read more
RECOMMENDATION: A Combined Rank of 1, is a sell recommendation based on Convatec Group's financial characteristics. As the company Convatec Group's key financial metrics all exhibit below-average performance, such as low value (Obermatt Value Rank of 47), low growth (Obermatt Growth Rank of 23), and risky financing practices (Obermatt Safety Rank of 12), it is a somewhat questionable stock investment, where the risk of paying too much for the shares is significant, unless the company has an exceptionally bright future. Such poor financial performance sometimes indicates that the company's business is all concentrated in some distant future. This is sometimes the case for high-tech or biotechnology companies. If they own properties that only provide cash flows in the future, the stock may look excessively expensive and risky today. In such cases, the Obermatt Method has limited value as it is based on facts we can observe today. If the facts are all in the future, stock investing becomes guesswork, and this should only be a driver in a limited number of investments that should only amount to a small fraction of a safe portfolio. Obermatt Premium subscribers can further check the stock’s Sentiment Ranks, which also flow into the Obermatt 360° View for investors. ...read more
Latest Obermatt Ranks
Log in or sign up to see the new 360° View and Sentiment ranks.
Country | United Kingdom |
Industry | Health Care Supplies |
Index | FTSE All Shares, FTSE 250, FTSE 350, Human Rights |
Size class | Large |
27-Mar-2025. Stock data may be delayed. Log in or sign up to get the most recent research.

Analysts rarely agree on a stock’s future. So, who do you believe? Obermatt translates those collective views into a single Sentiment Rank. That plus the financial ranks give you the ultimate 360° View. Sign up to access them.

It’s easier said than done. When your stock drops, it’s easy to want to sell it and find a better performer. Think twice, or even three times, before trading. Those fees (especially the hidden ones) can eat up your gains.
Review the performance ranks of the individual metrics that form each investment strategy.
Research History: Convatec Group
RESEARCH HISTORY | 2022 | 2023 | 2024 | 2025 | ||||
---|---|---|---|---|---|---|---|---|
VALUE | ||||||||
VALUE | 87 |
![]() |
53 |
![]() |
60 |
![]() |
47 |
![]() |
GROWTH | ||||||||
GROWTH | 7 |
![]() |
29 |
![]() |
10 |
![]() |
23 |
![]() |
SAFETY | ||||||||
SAFETY | 39 |
![]() |
8 |
![]() |
19 |
![]() |
12 |
![]() |
SENTIMENT | ||||||||
SENTIMENT | 66 |
![]() |
85 |
![]() |
80 |
![]() |
new | |
360° VIEW | ||||||||
360° VIEW | 51 |
![]() |
30 |
![]() |
32 |
![]() |
new |
Combined financial peformance in Detail
ANALYSIS: With an Obermatt Combined Rank of 1 (worse than 99% compared with investment alternatives), Convatec Group (Health Care Supplies, United Kingdom) shares have lower financial characteristics compared with similar stocks. Shares of Convatec Group are low in value (priced high) with a consolidated Value Rank of 47 (worse than 53% of alternatives), show below-average growth (Growth Rank of 23), and are riskily financed (Safety Rank of 12), which means above-average debt burdens. ...read more
RECOMMENDATION: A Combined Rank of 1, is a sell recommendation based on Convatec Group's financial characteristics. As the company Convatec Group's key financial metrics all exhibit below-average performance, such as low value (Obermatt Value Rank of 47), low growth (Obermatt Growth Rank of 23), and risky financing practices (Obermatt Safety Rank of 12), it is a somewhat questionable stock investment, where the risk of paying too much for the shares is significant, unless the company has an exceptionally bright future. Such poor financial performance sometimes indicates that the company's business is all concentrated in some distant future. This is sometimes the case for high-tech or biotechnology companies. If they own properties that only provide cash flows in the future, the stock may look excessively expensive and risky today. In such cases, the Obermatt Method has limited value as it is based on facts we can observe today. If the facts are all in the future, stock investing becomes guesswork, and this should only be a driver in a limited number of investments that should only amount to a small fraction of a safe portfolio. Obermatt Premium subscribers can further check the stock’s Sentiment Ranks, which also flow into the Obermatt 360° View for investors. ...read more
RESEARCH HISTORY | 2022 | 2023 | 2024 | 2025 | ||||
---|---|---|---|---|---|---|---|---|
VALUE | ||||||||
VALUE | 87 |
![]() |
53 |
![]() |
60 |
![]() |
47 |
![]() |
GROWTH | ||||||||
GROWTH | 7 |
![]() |
29 |
![]() |
10 |
![]() |
23 |
![]() |
SAFETY | ||||||||
SAFETY | 39 |
![]() |
8 |
![]() |
19 |
![]() |
12 |
![]() |
COMBINED | ||||||||
COMBINED | 33 |
![]() |
10 |
![]() |
1 |
![]() |
1 |
![]() |
Value Metrics in Detail
ANALYSIS: With an Obermatt Value Rank of 47 (worse than 53% compared with alternatives), Convatec Group shares are more expensive than the average comparable stock. The Value Rank is based on consolidating four value indicators, with half of the indicators below and half above average for Convatec Group. Price-to-Profit (also referred to as price-earnings, P/E) is 50 which means that the stock price compared with what market professionals expect for future profits is lower than for 50% of comparable companies, indicating a good value concerning Convatec Group's profit levels. The same is valid for Price-to-Book Capital (also referred to as market-to-book ratio) with a Price-to-Book Rank of 23, which means that the stock price is lower as regards to invested capital than for 23% of comparable investments. On the other hand, Price-to-Sales is less favorable than 57% of alternatives (only 43% of peers have an even less favorable ratio). The same is valid for dividend yield, which is lower than 33% of comparable companies, making the stock more expensive as regards to the company's expected dividend payouts. ...read more
RECOMMENDATION: The overall picture with a consolidated Value Rank of 47, is a hold recommendation based on Convatec Group's stock price compared with the company's operational size and dividend yields. This is a puzzling picture, because it means that profits are high while dividends are low. Since the stock price is low compared with invested capital but high in respect to expected revenues, it means that the company has more invested capital than peers for generating the same amount of revenue. Since profits are higher, it could be a "cash cow" situation (using the classic Boston Consulting BCG matrix naming convention) where the company is on a downward trend, still living from the profits of past products. As the company pays low dividends, it may harbor the opinion that a turnaround is possible, and it rather invests the cash than pay it out to shareholders, thus sealing the company's fate early. Any investment optimism should only be a buy trigger once thorough research is completed. We recommend further analyzing the stock with Obermatt’s Value, Safety, and Sentiment Ranks, including the 360° View, before making an investment decision, which is especially important in this case, as the financial indicators are inconclusive. ...read more
VALUE METRICS | 2022 | 2023 | 2024 | 2025 | ||||
---|---|---|---|---|---|---|---|---|
PRICE VS. REVENUES (P/S) | ||||||||
PRICE VS. REVENUES (P/S) | 78 |
![]() |
48 |
![]() |
49 |
![]() |
43 |
![]() |
PRICE VS. PROFITS (P/E) | ||||||||
PRICE VS. PROFITS (P/E) | 78 |
![]() |
50 |
![]() |
56 |
![]() |
50 |
![]() |
PRICE VS. CAPITAL (Market-to-Book) | ||||||||
PRICE VS. CAPITAL (Market-to-Book) | 73 |
![]() |
16 |
![]() |
22 |
![]() |
23 |
![]() |
DIVIDEND YIELD | ||||||||
DIVIDEND YIELD | 65 |
![]() |
74 |
![]() |
75 |
![]() |
67 |
![]() |
CONSOLIDATED RANK: VALUE | ||||||||
CONSOLIDATED RANK: VALUE | 87 |
![]() |
53 |
![]() |
60 |
![]() |
47 |
![]() |
Growth Metrics in Detail
ANALYSIS: With an Obermatt Growth Rank of 23 (better than 23% compared with alternatives), Convatec Group shows one of the most restricted growth dynamics in its industry. There is little momentum in this company. The Growth Rank is based on consolidating four value indicators, with three out of four metrics below average for Convatec Group. While Profit Growth has a good rank of 57, as professionals currently expect the company to grow its profits more than 57% of its competitors, all other growth indicators are below market averages. Sales Growth has a rank of 38, which means that currently professionals expect the company to grow less than 62% of its competitors, while Capital Growth has a rank of 17 and Stock Returns have been below market median, with a rank of 45 (55% of alternative investments were better). ...read more
RECOMMENDATION: The overall picture with a consolidated Growth Rank of 23, is a sell recommendation for growth and momentum investors. While revenue growth and capital growth are good growth momentum indicators, profit is less reliable, because profits may increase due to cost-cutting measures which typically indicate negative growth momentum. "You can save a dollar only once" is the saying about such situations. Growth Investors should look at company priorities closely if they are interested in growth, because the increase in profits is not usually an indicator of growth, and stock prices have been below market, too. While momentum is a popular investment factor, the value aspect might be the more important one, in the longer term. We recommend analyzing the stock with Obermatt’s Value, Safety, and Sentiment Ranks to arrive at a 360° View of the stock purchase case, especially since the growth performance is limited here. ...read more
GROWTH METRICS | 2022 | 2023 | 2024 | 2025 | ||||
---|---|---|---|---|---|---|---|---|
REVENUE GROWTH | ||||||||
REVENUE GROWTH | 17 |
![]() |
26 |
![]() |
4 |
![]() |
38 |
![]() |
PROFIT GROWTH | ||||||||
PROFIT GROWTH | 16 |
![]() |
52 |
![]() |
45 |
![]() |
57 |
![]() |
CAPITAL GROWTH | ||||||||
CAPITAL GROWTH | 34 |
![]() |
16 |
![]() |
25 |
![]() |
17 |
![]() |
STOCK RETURNS | ||||||||
STOCK RETURNS | 25 |
![]() |
65 |
![]() |
54 |
![]() |
45 |
![]() |
CONSOLIDATED RANK: GROWTH | ||||||||
CONSOLIDATED RANK: GROWTH | 7 |
![]() |
29 |
![]() |
10 |
![]() |
23 |
![]() |
Safety Metrics in Detail
ANALYSIS: With an Obermatt Safety Rank of 12 (better than 12% compared with alternatives), the company Convatec Group has much riskier financing practices than comparable other companies, which means that their overall debt burden is significantly above the industry average. This doesn't mean that the business of Convatec Group is also risky, it only means that the company is on the riskier side in respect to bankruptcy in case things turn sour, assuming that public reporting is correct. The Safety Rank is based on consolidating three financing indicators, with all three metrics below average for Convatec Group. Liquidity is at 27, meaning that the company generates less profit to service its debt than 73% of its competitors. This indicates that the company is on the riskier side when it comes to debt service. Even worse, Leverage is at a rank of 24, meaning the company has an above-average debt-to-equity ratio. It has more debt than 76% of its competitors. Finally, Refinancing is at a rank of 19 which means that the portion of the debt about to be refinanced is above average. It has more debt in the refinancing stage than 81% of its competitors. ...read more
RECOMMENDATION: With a consolidated Safety Rank of 12 (worse than 88% compared with alternatives), Convatec Group has a financing structure that is significantly riskier than that of its competitors. This combination is rather dangerous in most situations. Only very promising companies with bright future outlooks and stellar reputations can operate with such risky financing. Investors should look at Obermatt’s Value, Growth, and Sentiment Ranks to confirm a very positive outlook or be careful with investing in stocks of Convatec Group because it may suffer significantly in case of future difficulties. ...read more
SAFETY METRICS | 2022 | 2023 | 2024 | 2025 | ||||
---|---|---|---|---|---|---|---|---|
LEVERAGE | ||||||||
LEVERAGE | 18 |
![]() |
26 |
![]() |
23 |
![]() |
24 |
![]() |
REFINANCING | ||||||||
REFINANCING | 69 |
![]() |
23 |
![]() |
34 |
![]() |
19 |
![]() |
LIQUIDITY | ||||||||
LIQUIDITY | 33 |
![]() |
28 |
![]() |
32 |
![]() |
27 |
![]() |
CONSOLIDATED RANK: SAFETY | ||||||||
CONSOLIDATED RANK: SAFETY | 39 |
![]() |
8 |
![]() |
19 |
![]() |
12 |
![]() |
Sentiment Metrics in Detail
SENTIMENT | 2022 | 2023 | 2024 | 2025 | ||||
---|---|---|---|---|---|---|---|---|
ANALYST OPINIONS | ||||||||
ANALYST OPINIONS | n/a |
![]() |
82 |
![]() |
75 |
![]() |
new | |
OPINIONS CHANGE | ||||||||
OPINIONS CHANGE | 50 |
![]() |
46 |
![]() |
53 |
![]() |
new | |
PRO HOLDINGS | ||||||||
PRO HOLDINGS | 90 |
![]() |
54 |
![]() |
92 |
![]() |
new | |
MARKET PULSE | ||||||||
MARKET PULSE | 40 |
![]() |
74 |
![]() |
51 |
![]() |
new | |
CONSOLIDATED RANK: SENTIMENT | ||||||||
CONSOLIDATED RANK: SENTIMENT | 66 |
![]() |
85 |
![]() |
80 |
![]() |
new |
Free stock analysis by the purely fact based Obermatt Method for Convatec Group from March 27, 2025.
Obermatt Portfolio Performance
We’re so convinced about our free research, that we buy our stock tips.
See the performance of the Obermatt portfolio.